Neuberger Berman Group
SANA icon

Neuberger Berman Group’s Sana Biotechnology SANA Stock Holding History

Neuberger Berman Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.3K Buy
14,327
+3,581
+33% +$14.1K ﹤0.01% 2122
2025
Q4 		$43.7K Sell
10,746
-432
-4% -$1.93K ﹤0.01% 2061
2025
Q3 		$39.7K Buy
11,178
+251
+2% +$907 ﹤0.01% 2005
2025
Q2 		$29.8K Buy
10,927
+698
+7% +$1.44K ﹤0.01% 2006
2025
Q1 		$17.2K Buy
+10,229
New +$28.6K ﹤0.01% 1946

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Neuberger Berman Group's SANA Position: Q1 2026 in Review

Neuberger Berman Group increased its Sana Biotechnology (SANA) stake by 33% in Q1 2026, buying an estimated $14.1K and bringing the position to 14,327 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

Neuberger Berman Group first reported a position in SANA in Q1 2025 and has held it in 5 quarters since. The position peaked at $43.7K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Neuberger Berman Group held 14,327 shares of Sana Biotechnology worth $41.3K as of Q1 2026.
  • Neuberger Berman Group bought 3,581 Sana Biotechnology shares in Q1 2026, an estimated $14.1K.
  • Sana Biotechnology made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2122 holding.
  • Neuberger Berman Group first reported a position in Sana Biotechnology in Q1 2025 and has held it in 5 quarters since.
  • Neuberger Berman Group's Sana Biotechnology position peaked at $43.7K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.